Generare
Stub active Updated Apr 3, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Generare is a Paris-based techbio company founded in 2023 that builds the largest dataset of undiscovered molecular chemistry from microbial genomes for drug development 1. The company’s evolution-based platform unlocks information encoded within microbial genomes, cataloguing novel small molecules characterized by structure, biological activity, and drug potential 12. Generare serves pharmaceutical and agrochemical companies and aims to scale its discovery capacity tenfold by 2027 2.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-02 | Series A | €20M ($22.9M) | Alven, daphni | Galion.exe, Teampact Ventures, VIVES Partners 12 |
What Investors Say
No verified investor quotes available at this time.
What Founders Say
No verified founder quotes available at this time.
Sources
-
EU-Startups, “Paris-based Generare raises €20 million to generate novel molecular data for drug development from microbial genomes,” April 2, 2026. https://www.eu-startups.com/2026/04/paris-based-generare-raises-e20-million-to-generate-novel-molecular-data-for-drug-development-from-microbial-genomes↩↩↩
-
SiliconANGLE, “Generare raises $23.2M to discover unknown molecules and advance new drugs,” April 2, 2026. https://siliconangle.com/2026/04/02/generare-raises-23-2m-discover-unknown-molecules-advance-new-drugs/↩↩↩